Shimpei Iikuni

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 13

Top Venues

Molecular pharmaceutics

ACS chemical neuroscience

ACS medicinal chemistry letters

Chemical communications (Cambridge, England)

Kyoto University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Kyoto University Oct 01 2018

Japan

Assistant professor :: Graduate School of Pharmaceutical Sciences

Publications

Shimpei Iikuni, Ichiro Kamei, Takaki Ohara, Hiroyuki Watanabe, Masahiro Ono
Development of an 111 In-Labeled Glucagon-Like Peptide-1 Receptor-Targeting Exendin-4 Derivative that Exhibits Reduced Renal Uptake. Molecular pharmaceutics 19 (3) (2022)
Sho Kaide, Hiroyuki Watanabe, Shimpei Iikuni, Masato Hasegawa, Masahiro Ono
Synthesis and Evaluation of 18 F-Labeled Chalcone Analogue for Detection of α-Synuclein Aggregates in the Brain Using the Mouse Model. ACS chemical neuroscience 13 (20) (2022)
Kazuma Nakashima, Shimpei Iikuni, Hiroyuki Watanabe, Masahiro Ono
Application of the Chelator-Based Clickable Radiotheranostic Platform to Moderate-Molecular-Weight Ligands. ACS medicinal chemistry letters 13 (10) (2022)
Shimpei Iikuni, Yuta Tarumizu, Shohei Tsuchihashi, Takaki Ohara, Hiroyuki Watanabe, Masahiro Ono
Synthesis and Evaluation of Novel 111 In-Labeled Picolinic Acid-Based Radioligands Containing an Albumin Binder for Development of a Radiotheranostic Platform. Molecular pharmaceutics 19 (8) (2022)
Shimpei Iikuni, Takaki Ohara, Hiroyuki Watanabe, Masahiro Ono
Structure-Activity Relationships and Pharmacokinetics of 111 In-Labeled Glucagon-like Peptide-1 Receptor-Targeting Exendin-4 Derivatives Conjugated with Albumin Binder Moieties. Molecular pharmaceutics 19 (8) (2022)
Hiroyuki Watanabe, Rinka Maekawa, Shimpei Iikuni, Masashi Kakae, Nagisa Matsuo, Hisashi Shirakawa, Shuji Kaneko, Masahiro Ono
Characterization of Radioiodinated Diaryl Oxadiazole Derivatives as SPECT Probes for Detection of Myelin in Multiple Sclerosis. ACS chemical neuroscience 13 (3) (2022)
Hiroyuki Watanabe, Takeaki Kishimoto, Sho Kaide, Yuta Tarumizu, Haruka Tatsumi, Shimpei Iikuni, Masahiro Ono
Characterization and Optimization of Benzimidazopyrimidine and Pyridoimidazopyridine Derivatives as Tau-SPECT Probes. ACS medicinal chemistry letters 12 (5) (2021)
Shimpei Iikuni, Yuta Tarumizu, Kazuma Nakashima, Yusuke Higaki, Hiroaki Ichikawa, Hiroyuki Watanabe, Masahiro Ono
Radiotheranostics Using a Novel 225Ac-Labeled Radioligand with Improved Pharmacokinetics Targeting Prostate-Specific Membrane Antigen. Journal of medicinal chemistry 64 (18) (2021)
Kazuma Nakashima, Shimpei Iikuni, Hiroyuki Watanabe, Masahiro Ono
Development of a novel radiotheranostic platform with a DOTA-based trifunctional chelating agent. Chemical communications (Cambridge, England) 57 (52) (2021)
Shimpei Iikuni, Yuya Okada, Yoichi Shimizu, Hiroyuki Watanabe, Masahiro Ono
Modulation of the Pharmacokinetics of a Radioligand Targeting Carbonic Anhydrase-IX with Albumin-Binding Moieties. Molecular pharmaceutics 18 (3) (2021)
Sho Kaide, Hiroyuki Watanabe, Shimpei Iikuni, Masato Hasegawa, Kyoko Itoh, Masahiro Ono
Chalcone Analogue as New Candidate for Selective Detection of α-Synuclein Pathology. ACS chemical neuroscience 13 (1) (2021)
Sho Kaide, Hiroyuki Watanabe, Yoichi Shimizu, Shimpei Iikuni, Yuji Nakamoto, Masato Hasegawa, Kyoko Itoh, Masahiro Ono
Identification and Evaluation of Bisquinoline Scaffold as a New Candidate for α-Synuclein-PET Imaging. ACS chemical neuroscience 11 (24) (2020)
Shimpei Iikuni, Hiroyuki Watanabe, Yoichi Shimizu, Yuji Nakamoto, Masahiro Ono
PET imaging and pharmacological therapy targeting carbonic anhydrase-IX high-expressing tumors using US2 platform based on bivalent ureidosulfonamide. PloS one 15 (12) (2020)

Shimpei Iikuni.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Shimpei Iikuni